Stock Track | Castle Biosciences Surges After Smashing Q3 Earnings Estimates

Stock Track

2024-11-05

Castle Biosciences, Inc. (NASDAQ:CSTL) stock soared 5.53% in after-hours trading on November 4th after the company reported impressive third quarter 2024 financial results that handily beat Wall Street expectations.

For the quarter ended September 30, 2024, the company reported earnings per share (EPS) of $0.08, significantly higher than the consensus analyst estimate of -$0.03. Castle Biosciences' revenue came in at $85.8 million, up 39.53% year-over-year and surpassing the $79.842 million estimate by 7.46%.

The strong earnings beat and robust revenue growth underscored the continued strength of Castle Biosciences' business and its ability to drive profitability. Investors cheered the exceptional results, bidding the stock higher in extended trading as the company demonstrated its ability to exceed lofty expectations.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1179911745"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179911745\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1179911745?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-05 05:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179911745","market":"hk","top_or_hot":-1,"title":"Stock Track | Castle Biosciences Surges After Smashing Q3 Earnings Estimates","media":"Stock Track","content":"<p>Castle Biosciences, Inc. (NASDAQ:CSTL) stock soared 5.53% in after-hours trading on November 4th after the company reported impressive third quarter 2024 financial results that handily beat Wall Street expectations.</p>\n\n<p>For the quarter ended September 30, 2024, the company reported earnings per share (EPS) of $0.08, significantly higher than the consensus analyst estimate of -$0.03. Castle Biosciences' revenue came in at $85.8 million, up 39.53% year-over-year and surpassing the $79.842 million estimate by 7.46%.</p>\n\n<p>The strong earnings beat and robust revenue growth underscored the continued strength of Castle Biosciences' business and its ability to drive profitability. Investors cheered the exceptional results, bidding the stock higher in extended trading as the company demonstrated its ability to exceed lofty expectations.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Castle Biosciences Surges After Smashing Q3 Earnings Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Castle Biosciences Surges After Smashing Q3 Earnings Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-11-05 05:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Castle Biosciences, Inc. (NASDAQ:CSTL) stock soared 5.53% in after-hours trading on November 4th after the company reported impressive third quarter 2024 financial results that handily beat Wall Street expectations.</p>\n\n<p>For the quarter ended September 30, 2024, the company reported earnings per share (EPS) of $0.08, significantly higher than the consensus analyst estimate of -$0.03. Castle Biosciences' revenue came in at $85.8 million, up 39.53% year-over-year and surpassing the $79.842 million estimate by 7.46%.</p>\n\n<p>The strong earnings beat and robust revenue growth underscored the continued strength of Castle Biosciences' business and its ability to drive profitability. Investors cheered the exceptional results, bidding the stock higher in extended trading as the company demonstrated its ability to exceed lofty expectations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CSTL","symbol_name":"Castle Biosciences, Inc.","start_time":0,"source_url":"","article_id":"1179911745","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179911745","pubTimestamp":1730756542,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Castle Biosciences, Inc.  stock soared 5.53% in after-hours trading on November 4th after the company reported impressive third quarter 2024 financial results that handily beat Wall Street expectations.For the quarter ended September 30, 2024, the company reported earnings per share  of $0.08, significantly higher than the consensus analyst estimate of -$0.03. Castle Biosciences' revenue came in at $85.8 million, up 39.53% year-over-year and surpassing the $79.842 million estimate by 7.46%.The s","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CSTL":"Castle Biosciences, Inc."},"translate_title":"Castle Biosciences第三季度盈利预期大幅上涨","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSTL":1},"content_text":"Castle Biosciences, Inc. (NASDAQ:CSTL) stock soared 5.53% in after-hours trading on November 4th after the company reported impressive third quarter 2024 financial results that handily beat Wall Street expectations.\nFor the quarter ended September 30, 2024, the company reported earnings per share (EPS) of $0.08, significantly higher than the consensus analyst estimate of -$0.03. Castle Biosciences' revenue came in at $85.8 million, up 39.53% year-over-year and surpassing the $79.842 million estimate by 7.46%.\nThe strong earnings beat and robust revenue growth underscored the continued strength of Castle Biosciences' business and its ability to drive profitability. Investors cheered the exceptional results, bidding the stock higher in extended trading as the company demonstrated its ability to exceed lofty expectations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}